Astrana Health files interim financials of acquired Prospect entities; pro forma included

Astrana Health, Inc.

Acquired Business (PHPH & RI Market) nine-month net loss $38.7M vs $43.7M year-ago; total net revenue $961.8M (+9.6% YoY).
Operating income $48.5M vs $88.4M YoY; interest expense $121.8M drove pre-tax loss $73.4M.
Members' deficit $1.31B as of June 30, 2025, with long-term debt $777.8M and current debt $489.0M.
Pro forma condensed combined statement of operations for Astrana for fiscal year 2025 filed as Exhibit 99.2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.